“Virologic Response Following a Switch to Dolutegravir-Based Regimen in People Living With HIV AIDS at a Tertiary Care Center in Nepal”. 2022. Kathmandu University Medical Journal 20 (4): 438-42. https://doi.org/10.3126/kumj.v20i4.54081.